National Cancer Institute; Notice of Meeting, 6913 [2014-02322]
Download as PDF
Federal Register / Vol. 79, No. 24 / Wednesday, February 5, 2014 / Notices
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Barba Koroma, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3196,
Bethesda, MD 20892, 301–594–3292,
koromabm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: January 30, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–02316 Filed 2–4–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: January 30, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
National Cancer Institute; Notice of
Meeting
[FR Doc. 2014–02322 Filed 2–4–14; 8:45 am]
BILLING CODE 4140–01–P
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Board of
Scientific Advisors.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: March 6, 2014.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: Director’s Report: Ongoing and
New Business; Reports of Program Review
Group(s); and Budget Presentations, Reports
of Special Initiatives; RFA and RFP Concept
Reviews; and Scientific Presentations.
Place: National Institutes of Health,
Building 31, 6th Floor, Conf. Rm. 10, 31
Center Drive, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, Ph.D.,
Executive Secretary, Division of Extramural
Activities, National Cancer Institute—Shady
Grove, National Institutes of Health, 9609
Medical Center Drive, 7th Floor, Rm. 7W444,
Bethesda, MD 20892, 240–276–6340, grayp@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
VerDate Mar<15>2010
16:50 Feb 04, 2014
Jkt 232001
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsa/bsa.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS).
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
DEPARTMENT OF STATE
Office of the Secretary
Exercise of Authority Under Section
212(d)(3)(B)(i) of the Immigration and
Nationality Act
Office of the Secretary, DHS;
Office of the Secretary, DOS.
ACTION: Notice of determination.
AGENCIES:
Authority: 8 U.S.C. 1182(d)(3)(B)(i)
Following consultations with the
Attorney General, the Secretary of
Homeland Security and the Secretary of
State have determined that grounds of
inadmissibility at section 212(a)(3)(B) of
the Immigration and Nationality Act
(INA), 8 U.S.C. 1182(a)(3)(B), bar certain
aliens who do not pose a national
security or public safety risk from
admission to the United States and from
obtaining immigration benefits or other
status. Accordingly, consistent with
prior exercises of the exemption
authority, the Secretary of Homeland
Security and the Secretary of State, in
consultation with the Attorney General,
hereby conclude, as a matter of
discretion in accordance with the
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
6913
authority granted by INA section
212(d)(3)(B)(i), 8 U.S.C. 1182(d)(3)(B)(i),
as amended, as well as the foreign
policy and national security interests
deemed relevant in these consultations,
that paragraphs 212(a)(3)(B)(iv)(VI)(bb)
and (dd) of the INA, 8 U.S.C.
1182(a)(3)(B)(iv)(VI)(bb) and (dd), shall
not apply with respect to an alien who
provided insignificant material support
to an organization described in section
212(a)(3)(B)(vi)(III) of the INA, 8 U.S.C.
1182(a)(3)(B)(vi)(III), or to a member of
such an organization, or to an
individual described in section
212(a)(3)(B)((iv)(VI)(bb) of the INA, 8
U.S.C. 1182(a)(3)(B)(iv)(VI)(bb),
provided that the alien satisfies the
relevant agency authority that the alien:
(a) Is seeking a benefit or protection
under the INA and has been determined
to be otherwise eligible for the benefit
or protection;
(b) has undergone and passed all
relevant background and security
checks;
(c) has fully disclosed, in all relevant
applications and/or interviews with
U.S. government representatives and
agents, the nature and circumstances of
any material support provided and any
other activity or association falling
within the scope of section 212(a)(3)(B)
of the INA, 8 U.S.C. 1182(a)(3)(B), as
well as all contact with a terrorist
organization and its members;
(d) has not provided more than an
insignificant amount of material support
to a terrorist organization described in
section 212(a)(3)(B)(vi)(III) of the INA, 8
U.S.C. 1182(a)(3)(B)(vi)(III), or to a
member of such an organization, or to
an individual described in section
212(a)(3)(B)(iv)(VI)(bb) of the INA, 8
U.S.C. 1182 (a)(3)(B)(iv)(VI)(bb);
(e) (1) has not provided the material
support with any intent of furthering the
terrorist or violent activities of the
individual or organization; (2) has not
provided material support that the alien
knew or reasonably should have known
could directly be used to engage in
terrorist or violent activity; and (3) has
not provided material support to any
individual who the alien knew or
reasonably should have known had
committed or planned to commit a
terrorist activity on behalf of a
designated terrorist organization, as
described in section 212(a)(3)(B)(vi)(I) or
(II) of the INA, 8 U.S.C.
1182(a)(3)(B)(vi)(I) or (II);
(f) has not provided material support
to terrorist activities that he or she knew
or reasonably should have known
targeted noncombatant persons, U.S.
citizens, or U.S. interests;
(g) has not provided material support
that the alien knew or reasonably
E:\FR\FM\05FEN1.SGM
05FEN1
Agencies
[Federal Register Volume 79, Number 24 (Wednesday, February 5, 2014)]
[Notices]
[Page 6913]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-02322]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Cancer Institute Board of Scientific Advisors.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Cancer Institute Board of Scientific
Advisors.
Date: March 6, 2014.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: Director's Report: Ongoing and New Business; Reports of
Program Review Group(s); and Budget Presentations, Reports of
Special Initiatives; RFA and RFP Concept Reviews; and Scientific
Presentations.
Place: National Institutes of Health, Building 31, 6th Floor,
Conf. Rm. 10, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, Ph.D., Executive Secretary,
Division of Extramural Activities, National Cancer Institute--Shady
Grove, National Institutes of Health, 9609 Medical Center Drive, 7th
Floor, Rm. 7W444, Bethesda, MD 20892, 240-276-6340,
grayp@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/bsa/bsa.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS).
Dated: January 30, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-02322 Filed 2-4-14; 8:45 am]
BILLING CODE 4140-01-P